Drug Overdose Prevention Information

Having trouble viewing this email? View it as a Web page.

PDO email header

October 23, 2018

Here are your weekly opioid epidemic updates from the Indiana State Department of Health:

National Drug Take Back Day –

Oct. 27

DEA drug take back

The Drug Enforcement Administration is hosting the 15th national drug take back day on Saturday, Oct. 27, across thousands of locations nationwide. The goal of the event is to encourage the public to clean out their medicine cabinets and turn in their unwanted prescription drugs safely and anonymously. To search for a take back location near you, use the online navigator.

New resources for ED clinicians interested in initiating buprenorphine treatment

The National Institute on Drug Abuse recently announced the availability of informational resources for clinicians interested in initiating buprenorphine treatment in emergency department (ED) settings. Buprenorphine is one of several medicines available for use in many emergency departments to treat opioid use disorders. ED physicians often reverse overdoses using the medication naloxone, however, that medication does not constitute treatment for the addiction itself. This makes the emergency setting an ideal place for clinicians to begin treatment conversations with patients, and this comprehensive set of tools includes information on best practices as well as case-based videos to provide emergency department clinicians with effective strategies and conversation tips to treat people with opioid use disorders.

New Quality Improvement and Care Coordination Resource released


The Centers for Disease Control and Prevention’s (CDC’s) National Center for Injury Prevention and Control has developed and released the Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain. The quality improvement measures provided in the resource are flexible so that healthcare systems and practice leaders can pick which interventions will work best for their practices and patient populations. They are offered as voluntary measures that could help incorporate the evidence contained in CDC’s Guideline for Prescribing Opioids for Chronic Pain in clinical workflow. To access the resource and supporting materials, visit CDC’s website.

Treatment center in Carmel is the first in the Midwest to offer new Sublocade MAT

Lucina Treatment Center in Carmel is the first substance abuse treatment center in the Midwest to offer Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients. Buprenorphine is approved to be administered as a tablet or film that dissolves in the mouth or as an implant. Sublocade provides a new treatment option for patients in recovery who may value the benefits of a once-monthly injection compared to other forms of buprenorphine, such as reducing the burden of taking medication daily as prescribed.

Follow us! @INDTrauma

light blue divider

Check out our website

world wide web logo
light blue divider


Webcast: First Responder Burnout Prevention

October 23, 2pm
This webinar will examine the causes of first responder burnout with consideration given to stresses arising from response to the opioid epidemic. Panelists will discuss methods to identify burnout in first responders or their partners, and recommendations to help first responders access resources to manage stress more effectively. Register here.

light blue divider

Webcast: State Options for Promoting Recovery among Pregnant and Parenting Women with SUD

October 24, 1pm
This webinar will highlight Colorado- a state that is coordinating across agencies and systems to meet the needs of pregnant and parenting women affected by substance use disorder (SUD). Speakers will describe the coverage, financing, and care delivery strategies that their state agencies leverage to facilitate recovery among pregnant and parenting women with SUD. Register here.

light blue divider

2018 Indiana Drug Abuse Symposium

October 29-30, 7:30am-4:30pm
Registration is now open for the 9th Annual Indiana Drug Abuse Symposium, hosted by the Indiana Attorney General's Office.  
Location: Noblesville, IN

light blue divider

Webcast: Deflection & Pre-Arrest Diversion

October 31, 2:00pm
In 2018, Illinois became the first state sign into law comprehensive 5-pathway deflection legislation. This webinar will present the ins and outs of this legislation and present a path for communities across the U.S. to do the same in support of the newly emerging field of deflection and pre-arrest diversion. Register here.

light blue divider

Register for the MIPA conference!


November 29-30, 2018
This year’s conference will focus on a variety of injury and violence prevention topics, including prescription drug overdose, older adult falls, emerging hazards in child injury, and other primary injury prevention topics. Additionally, it will include presentations focusing on pediatric and adult injury prevention. Registration is now open.
Location: Indianapolis, IN